Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

572
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
572

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ECTOPIC THYROID PRESENTING AS MEDIASTINAL MASS.

Acta endocrinologica (Bucharest, Romania : 2005)·2025
Same author

Response Letter to Laurelli et al. Letter to the Editor Regarding Enhancing Telemedicine to Improve Global Radiotherapy Access.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Simultaneous implementation of unrelated tumour sites on the MR Linac: A review of the commissioning process from a radiographer perspective and lessons learned.

Journal of medical imaging and radiation sciences·2024
Same author

Expanding Global Radiotherapy Access via Telemedicine.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study.

Acta oncologica (Stockholm, Sweden)·2022

Related Experiment Video

Updated: Dec 17, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K

Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?

T S Lewis1, J A Kennedy1, G J Price2

  • 1Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|July 1, 2020
PubMed
Summary
This summary is machine-generated.

Higher palliative lung radiotherapy doses of up to 30 Gy/10 fractions improved patient survival, irrespective of performance status. This finding offers valuable insights for optimizing lung cancer treatment strategies.

Keywords:
Lung canceroutcomes researchpalliative careradiotherapy

More Related Videos

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.4K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.5K

Related Experiment Videos

Last Updated: Dec 17, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.4K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.5K

Area of Science:

  • Oncology
  • Radiotherapy
  • Palliative Care

Background:

  • Optimal palliative lung radiotherapy regimens are challenging to determine.
  • Current guidelines recommend treatment stratification by performance status.
  • Emerging evidence suggests higher radiotherapy doses may improve survival.

Purpose of the Study:

  • To investigate the impact of fractionation regimen and other factors on survival in palliative lung cancer radiotherapy patients.
  • To analyze the prognostic significance of patient characteristics and treatment prescriptions.
  • To evaluate the association between radiotherapy dose and survival outcomes.

Main Methods:

  • Retrospective analysis of 925 patients with non-small cell and small cell lung cancer.
  • Univariable and multivariable survival analyses were performed.
  • Investigated covariates included performance status, histology, smoking status, and fractionation scheme.

Main Results:

  • Performance status, fractionation scheme, comorbidities, histology, smoking status, and gender were associated with survival in univariable analysis.
  • Multivariable analysis identified better performance status and increased dose/fractionation (up to 30 Gy/10 fractions) as significant survival predictors.
  • Mortality rates at 30 and 90 days were 9.2% and 34%, respectively.

Conclusions:

  • Increased total radiotherapy dose (up to 30 Gy/10 fractions) was linked to better survival in palliative lung cancer patients.
  • This association was observed regardless of patient performance status.
  • Findings suggest optimizing radiotherapy dosage may enhance survival outcomes in palliative settings.